fig3

Melatonin ameliorates tauopathy and ferroptosis in P301S Tau transgenic mice

Figure 3. Melatonin relieves synaptic dysfunction and neuronal damage in P301S mice. (A) Nissl staining indicating the functional states of neurons in the hippocampal CA1 region of melatonin- and vehicle-treated P301S mice. Scale bar = 20 μm; (B) Immunohistochemical staining results of MAP2 in the hippocampal CA1 region of P301S mice. Scale bar = 50 μm; (C-F) Immunoblotting results showing the levels of MAP2, NeuN, PSD95, and SYP in the P301S mouse brains after melatonin treatment. GAPDH served as an internal control. Values are represented as mean ± SEM (n = 8). *P < 0.05. MAP2: Microtubule-associated protein 2; PSD95: postsynaptic density protein 95; SYP: synaptophysin; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; SEM: standard error of the mean.

Ageing and Neurodegenerative Diseases
ISSN 2769-5301 (Online)

Portico

All published articles will be preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will be preserved here permanently:

https://www.portico.org/publishers/oae/